Patent · US Active

Compositions for inhibiting MASP-2 dependent complement activation

US11613589B2 · kind B2 · utility

0Cited by

18References

13Claims

0Family size

Assignee

Omeros Corporation · US

Inventors

Thomas Dudler · Bellevue, US
Wayne R. Gombotz · Kenmore, US
James Brian Parent · Bainbridge Island, US
Clark E. Tedford · Poulsbo, US
Anita Kavlie · Oslo, NO
Urs Beat Hagemann · Oslo, NO
Herald Reiersen · Sofiemyr, NO
Sergej Kiprijanov · Oslo, NO

Key dates

Filing date	Apr 24, 2020
Grant date	Mar 28, 2023
Priority date	—
Expiry date	Jun 25, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.